Bookmark and Share

NVIDIA, Massachusetts General Hospital Use Artificial Intelligence to Advance Radiology, Pathology, Genomics

SAN JOSE, CA--(Marketwired - Apr 5, 2016) - GPU Technology Conference -- NVIDIA (NASDAQ: NVDA) today announced that it is a founding technology partner of the MGH Clinical Data Science Center, which aims to advance healthcare by applying the latest artificial intelligence techniques to improve the detection, diagnosis, treatment and management of diseases.

Massachusetts General Hospital -- which conducts the largest hospital-based research program in the United States, and is the top-ranked hospital on this year's US News and World Report "Best Hospitals" list -- recently established the MGH Clinical Data Science Center in Boston. The center will train a deep neural network using Mass General's vast stores of phenotypic, genetics and imaging data. The hospital has a database containing some 10 billion medical images.

To process this massive amount of data, the center will deploy the NVIDIA® DGX-1™ -- a server designed for AI applications, launched earlier today at the GPU Technology Conference -- and deep learning algorithms created by NVIDIA engineers and Mass General data scientists.

"Deep learning is revolutionizing a wide range of scientific fields," said Jen-Hsun Huang, CEO and co-founder, NVIDIA. "There could be no more important application of this new capability than improving patient care. This work will one day benefit millions of people by extending the capabilities of physicians with an incredibly powerful new tool."

Using AI, physicians can compare a patient's symptoms, tests and history with insight from a vast population of other patients. Initially, the MGH Clinical Data Science Center will focus on the fields of radiology and pathology -- which are particularly rich in images and data -- and then expand into genomics and electronic health records.

"We now have the ability to expand the field of radiology beyond its predominant state of providing visualization for human interpretation," said Dr. Keith J. Dreyer, vice chairman of Radiology at Mass General, associate professor of radiology at Harvard Medical School and executive director of the center. "Guided by precision healthcare, we are entering the radiological era of biometric quantification, where our interpretations will be enhanced by algorithms learned from the diagnostic data of vast patient populations. Without the processing capabilities of GPUs, this would not be possible."

Keep Current on NVIDIA

Subscribe to the NVIDIA blog, follow us on Facebook, Google+, Twitter, LinkedIn and Instagram, and view NVIDIA videos on YouTube and images on Flickr.

About NVIDIA

NVIDIA (NASDAQ: NVDA) is a computer technology company that has pioneered GPU-accelerated computing. It targets the world's the most demanding users -- gamers, designers and scientists -- with products, services and software that power amazing experiences in virtual reality, artificial intelligence, professional visualization and autonomous cars. More information at http://nvidianews.nvidia.com/.